Tag:
Wyeth
Latest Headlines
Latest Headlines
Wyeth puts $960M squeeze on Sun for Protonix launch
Sun Pharmaceuticals ' at-risk launch of generic Protonix may prove to have been risky indeed. Pfizer's ( $PFE ) Wyeth unit slapped the Indian drugmaker with a $960 million damages claim, alleging Sun's
Pfizer targets approval for new menopause drug
Pfizer ( $PFE ) hasn't given up on the experimental menopause drug Aprela despite delays in the program, and the drug giant aims to file for FDA approval of the treatment sometime this year, the
For Pfizer, 5,000 lawsuits resolved, 5,000 to go
Pfizer initially faced more than 10,000 lawsuits claiming that its hormone replacement drugs such as Prempro and Premarin cause breast cancer. But the world's largest drugmaker ( $PFE ) has now settled
Pfizer briefs NJ public on Superfund site cleanup
Pfizer ( $PFE ) is all for spreading the word about its cleanup of a contaminated New Jersey site inherited through its acquisition of Wyeth. The drug giant is conducting a PR campaign to inform the
Pfizer ordered to pay $72M in Prempro case
A Philadelphia jury awarded $72 million to three women who blame their breast cancer on Pfizer's hormone-replacement drugs. It's just the latest in the drugmaker's battle over hormone drugs made by
Pfizer near agreement to resolve bribery probe
The U.S. government's Foreign Corrupt Practices Act crackdown rolls on, with Pfizer ( $PFE ) becoming the latest drugmaker to reach a tentative deal. The company disclosed that it's close to a final
SCOTUS won't look at Wyeth HRT case
The U.S. Supreme Court won't hear an appeal from Pfizer's Wyeth unit of a ruling in a Nevada hormone-therapy lawsuit. The case involved three women who claimed they developed breast cancer after
Appeals court finds for Boston Sci in stent case
A federal appeals court has given Boston Scientific a victory in a patent-infringement dispute with Johnson & Johnson in a case involving drug-eluting stents. The U.S. Court of Appeals for the
Pfizer in talks with feds on Protonix rebate charges
Pfizer ( $PFE ) is negotiating with the U.S. government to settle claims that it overcharged Medicaid for the stomach drug Protonix, Pharmalot reports, citing legal documents filed in a Boston federal
Supremes restrict vaccine claims to special court
Experts trump juries when it comes to vaccine-injury claims, the U.S. Supreme Court decided. In other words, parents and injured victims can't sue vaccine makers in state court, because a 1986 law
